Yuvraj_pawp, Author at Pharma Advancement

Strong second quarter and first half results reported -- Full year 2014 sales and profit guidance increased -- Conference call...

FDA approves Jardiance tablets for type 2 diabetes

by Yuvraj_pawp

4th August 2014

The US Food and Drug Administration (FDA) has approved Jardiance (empagliflozin) tablets, developed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly...

Genoa Pharmaceuticals Receives Orphan-Drug Designation for Pirfenidone in the Inhaled Treatment of Idiopathic Pulmonary Fibrosis

by Yuvraj_pawp

4th August 2014

Genoa Pharmaceuticals, the leader in inhaled medicines for pulmonary fibrosis, today announced the U.S. Food and Drug Administration (FDA) has...

Patheon Now Working as One with DSM Fine Chemicals and Banner Life Sciences

by Yuvraj_pawp

4th August 2014

Patheon has long been a trusted partner for the development and manufacture of high-quality pharmaceutical drug products. Now we have...

Patheon Now Working as One with DSM Fine Chemicals and Banner Life Sciences

by Yuvraj_pawp

4th August 2014

Patheon has long been a trusted partner for the development and manufacture of high-quality pharmaceutical drug products. Now we have...

Pharmaceuticals Learning the Language of the New Healthcare Landscape

by Yuvraj_pawp

4th August 2014

With monumental health reform coming into effect, the pharmaceutical industry is learning to speak a second language. Clinical efficacy is...

Vertex obtains receives European approval for cystic fibrosis oral medicine

by Yuvraj_pawp

4th August 2014

The European Commission has approved Vertex Pharmaceuticals' oral medicine Kalydeco (ivacaftor) for people with cystic fibrosis (CF). Kalydeco is for...

Rosetta Genomics Announces Agreement With Global Pharmaceutical Company to Advance Efforts in Alzheimer’s Disease Diagnostics

by Yuvraj_pawp

1st August 2014

Rosetta Genomics Announces Agreement With Global Pharmaceutical Company to Advance Efforts in Alzheimer's Disease Diagnostics. Leverages Rosetta's microRNA Biomarker Platform...

Pfizer to acquire Baxter’s portfolio of marketed vaccines for $635m

by Yuvraj_pawp

1st August 2014

Pfizer and Baxter have entered into a definitive agreement under which Pfizer will acquire Baxter's portfolio of marketed vaccines for...

Meda agrees to acquire Rottapharm for €2.3bn

by Yuvraj_pawp

1st August 2014

Swedish drugmaker Meda has agreed to acquire Italy-based Rottapharm Madaus for around €2.3bn as part of its strategy to boost...

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

AI Revolutionizing Drug Discovery and Clinical Development

China’s Super Me-Too Drug Development: A New Pharma Frontier

Asia Pacific Omics-Based Clinical Trials Market Growth

AstraZeneca Eyes Acquisition To Develop Cell Therapies

Advanced Instruments All Set To Merge With Nova Biomedical

Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

Oracle Wins the Asia Pacific Biopharma Excellence Awards

Continuous Manufacturing is Improving Biopharma Production

AI in Drug Commercialization Market to Grow CAGR 24% by 2032

AI Revolutionizing Drug Discovery and Clinical Development

China’s Super Me-Too Drug Development: A New Pharma Frontier

Asia Pacific Omics-Based Clinical Trials Market Growth

AstraZeneca Eyes Acquisition To Develop Cell Therapies

Advanced Instruments All Set To Merge With Nova Biomedical

Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

Oracle Wins the Asia Pacific Biopharma Excellence Awards

Continuous Manufacturing is Improving Biopharma Production

AI in Drug Commercialization Market to Grow CAGR 24% by 2032

Yuvraj_pawp

Cambrex Reports Second Quarter 2014 Financial Results

FDA approves Jardiance tablets for type 2 diabetes

Genoa Pharmaceuticals Receives Orphan-Drug Designation for Pirfenidone in the Inhaled Treatment of Idiopathic Pulmonary Fibrosis

Patheon Now Working as One with DSM Fine Chemicals and Banner Life Sciences

Patheon Now Working as One with DSM Fine Chemicals and Banner Life Sciences

Pharmaceuticals Learning the Language of the New Healthcare Landscape

Vertex obtains receives European approval for cystic fibrosis oral medicine

Rosetta Genomics Announces Agreement With Global Pharmaceutical Company to Advance Efforts in Alzheimer’s Disease Diagnostics

Pfizer to acquire Baxter’s portfolio of marketed vaccines for $635m

Meda agrees to acquire Rottapharm for €2.3bn

Qucik Links

About Us

Subscribe Us

System

Resources

Retrieve your password